Funding Details
- Awarder
- RSS - feed.businesswire.com
- Date Award
- August 02, 2024
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2021
- Organizations Involved
- St. Jude Children’s Research Hospital
- Founders
- Emil Kakkis, M.D., Ph.D.
- Company Description
- Amlogenyx, a subsidiary of Ultragenyx Pharmaceutical, Inc., is researching and developing novel gene therapies for Alzheimer’s disease and other amyloid diseases.
- Market
- Alzheimer's Disease and Amyloid Diseases
- Location
-
Beverly Hills,
CA,
US
- Coinvestors
- Ultragenyx Pharmaceutical, Inc.
Links